Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 7.379.2311.659.789.67

What is the latest Core EBITDA Margin ratio of ANUH PHARMA ?

The latest Core EBITDA Margin ratio of ANUH PHARMA is 7.37 based on Mar2026 Standalone results.
Year Core EBITDA Margin
Mar20267.37
Mar20259.23
Mar202411.65
Mar20239.78
Mar20229.67

How is Core EBITDA Margin of ANUH PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2026 7.37
-20.15
Mar2025 9.23
-20.77
Mar2024 11.65
19.12
Mar2023 9.78
1.14
Mar2022 9.67 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Margin ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹879.0 Cr -2% 10.2% 1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -5.4% 12% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr 0.7% 3.2% 61.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,740.0 Cr -2.8% -3% 32.6% Stock Analytics
CIPLA ₹108,497.0 Cr -2.9% -3.3% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -3.3% 4.7% -2.2% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-2%

10.2%

1.4%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses